Future experiments to evaluate the integrity of the Wnt/B-catenin signaling pathway in HA15-treated PEL cells will help clarify the contributions of BiP to changes in the proliferation capacity of these lymphoma-derived cells. Here, HSPA5 is linked to lymphoma.